Clarivate Plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CLVT | CNXC | III | INOD | GLOB | SAIC | |
|---|---|---|---|---|---|---|
| Market cap | 1.03B | 1.56B | 281.28M | 2.06B | 1.57B | 5.57B |
| P/E (TTM) | — | — | 24.2 | 46.4 | 14.2 | 15.5 |
| Forward P/E | 2.1 | 2.2 | 13.2 | 28.7 | 5.9 | 11.6 |
| Price/book | 0.2 | 0.9 | 2.9 | 12.9 | 0.7 | 4.0 |
| Dividend yield | — | 5.71% | 3.11% | — | — | 1.10% |
| 1-year change | −55.65% | −42.10% | +8.43% | −24.05% | −38.80% | +39.83% |
| Today | 0.00% | −1.85% | +0.35% | −3.43% | +0.30% | −1.20% |
The closest companies by business and industry (Information Technology Services). Prices may be delayed up to 15 min.
Latest news
All CLVT news ›Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business
Latham & Watkins LLP Altaris, LLC (collectively with its managed funds, Altaris) has announced that it completed the acquisition of the Life Sciences & Healthcare business from Clarivate plc (NYSE: CLVT). Latham & Watkins LLP represented…
Clarins - The Clarins Sweet Spot
To celebrate a decade of Clarins' best-selling Lip Comfort Oil, we needed more than an anniversary moment; we needed to win over a new generation of beauty lovers. So we ditched the counter and built a bakery instead. The Clarins Sweet…
Altaris Completes Acquisition of Clarivate’s Life Sciences & Healthcare Business
Confidently make smart, patient-centric decisions and navigate roadblocks with the help of AI-powered intelligence platforms that are fueled by extensive and specialized therapeutic area data and contextualized insights. Medtech Trends to…
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
06 Oct, 2026, 20:15 GMT Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments "I want to thank our Life Sciences & Healthcare colleagues for their many contributions to Clarivate and wish…
Clarivate (NYSE:CLVT) Sets New 1-Year Low – What’s Next?
Posted by Michael Walen on Oct 7th, 2026 Clarivate PLC (NYSE:CLVT – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Monday. The stock traded as low as $1.47 and last traded at $1.4650, with a volume of…
Clarivate Plc : Insider Transactions
Follow insider transactions on Clarivate Plc in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Clarivate Plc Latest insider transactions for Clarivate Plc All financial…
All Transcripts on Clarivate Plc (CLVT)
Find all the latest transcripts on Clarivate Plc All financial news and data tailored to specific country editions
Clarivate Plc: Latest Headlines - NYSE Stock Exchange
Find the latest highlights on Clarivate Plc at the NYSE stock exchange. All financial news and data tailored to specific country editions
Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment
marketscreener.com Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment Published on 10/06/2026 at 04:52 pm EDT
Clarivate Names Michael Easton as CFO
Clarivate said Wednesday that it has appointed Michael Easton as executive vice president and chief financial officer, effective Aug. 8. Easton succeeds Jonathan Collins, who is stepping down from... Clarivate Names Michael Easton as CFO…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com10
-
marketbeat.com3
-
bebeez.eu2
-
prnewswire.com2
-
clarivate.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.